How to Document Neurology Patient Visits and Neurological Examinations

Why Neurology Documentation Is Its Own Skill

The neurological examination is one of the most detailed and systematized assessments in all of medicine. It is also one of the easiest to document poorly. Clinicians in other specialties can get away with a brief, templated exam note. In neurology, an incomplete or vague exam note creates real problems: it fails to establish a baseline, it obscures the trajectory of complex diseases, and it may not support the billing level that a thorough neurological evaluation warrants.

Neurology visits involve findings that are dense, technical, and highly specific. A note that says "neuro exam normal" communicates almost nothing to a referring physician, a consulting specialist, or a malpractice reviewer. A note that systematically walks through cranial nerves, motor function, sensation, reflexes, coordination, and gait tells the full clinical story.

This guide is written for neurologists, neurology residents, and physicians doing neurological assessments. It covers how to document each component of the structured neurological examination, how to write neurology-specific SOAP notes, how to capture cognitive screening results, and how to handle the documentation requirements for common neurological presentations including seizures, headache and migraine visits, and stroke follow-up.

The Structured Neurological Examination: Section by Section

The neurological examination is typically organized into six domains. Each domain should appear as a distinct section in your note, even if findings are normal. Absence of documentation is not the same as absence of pathology, and a future reader needs to know that each domain was assessed.

Cranial Nerves

Document each of the twelve cranial nerves (CN I-XII) individually or in logical groupings. Grouping is acceptable when findings are normal and efficiency matters, but any abnormal finding should be documented separately with specific detail.

Example of a complete, efficient normal cranial nerve examination:

"Cranial nerves: CN I not formally tested (no olfactory complaints reported). CN II: visual acuity 20/25 OD, 20/30 OS by Snellen chart; visual fields full to confrontation bilaterally; funduscopic exam shows sharp disc margins with cup-to-disc ratio 0.3 bilaterally, no papilledema, no hemorrhages. CN III, IV, VI: extraocular movements intact in all directions, no nystagmus, no diplopia; pupils 4 mm bilaterally, equal, round, and reactive to light with intact accommodation. CN V: facial sensation intact to light touch in all three divisions bilaterally; masseter and temporalis bulk and strength symmetric; corneal reflexes intact bilaterally. CN VII: facial symmetry at rest and with volitional movement; forehead wrinkles symmetrically; no nasolabial fold flattening. CN VIII: hearing intact to finger rub bilaterally; Rinne and Weber tests deferred. CN IX, X: palate elevates symmetrically; gag reflex present bilaterally; speech without dysarthria or hypophonia. CN XI: sternocleidomastoid and trapezius strength 5/5 bilaterally. CN XII: tongue protrudes midline, no fasciculations, no atrophy."

Example of an abnormal finding requiring specific documentation:

"CN III (right): right ptosis present, approximately 4 mm with partial eyelid elevation on right. Right pupil 6 mm, minimally reactive to direct light, consensual response diminished. Left pupil 3 mm, briskly reactive. Right eye at rest in a down-and-out position. Extraocular movements: right eye with impaired adduction, supraduction, and infraduction. Left eye intact. Concerning for right CN III palsy; pupil-involving quality raises concern for compressive etiology. MRI/MRA ordered."

Motor System

The motor examination documents muscle bulk, tone, and strength across major muscle groups. Use the Medical Research Council (MRC) scale (0-5) and document specific muscle groups, not just limbs.

Standard documentation format:

"Motor: Bulk normal throughout, no focal atrophy or hypertrophy. Tone: normal in upper and lower extremities bilaterally, no rigidity, no spasticity, no cogwheeling. Drift: no pronator drift bilaterally. Strength (MRC scale): deltoids 5/5 bilaterally, biceps 5/5 bilaterally, triceps 5/5 bilaterally, wrist extensors 5/5 bilaterally, hand grip and interossei 5/5 bilaterally. Hip flexors 5/5 bilaterally, hip extensors 5/5 bilaterally, knee extensors 5/5 bilaterally, ankle dorsiflexion 5/5 bilaterally, ankle plantar flexion 5/5 bilaterally. No fasiculations observed."

When documenting weakness, be precise about the distribution. "Mild right hand weakness" is far less useful than "right wrist extension 4/5, finger extension 4-/5, hand intrinsics 4/5, with normal proximal upper extremity strength bilaterally." The distribution tells you something about localization.

Sensory Examination

The sensory examination should document the modalities tested and the distribution of any abnormality. Primary modalities include light touch, pin-prick (pain), temperature, vibration, and proprioception (joint position sense). Cortical sensory testing (graphesthesia, stereognosis, two-point discrimination) is added when cortical pathology is suspected.

Example of sensory documentation with a finding:

"Sensory: Light touch intact to the wrists bilaterally. Decreased light touch below the knees bilaterally, in a symmetric stocking distribution, most dense at the dorsum of the feet. Pin-prick: mild reduction below mid-calf bilaterally, symmetric. Temperature testing deferred. Vibration: markedly reduced at the great toes bilaterally (0/8 on 128 Hz tuning fork), mild reduction at the ankles bilaterally; intact at the knees. Proprioception: impaired at the great toes bilaterally (2/5 correct on small-amplitude tests), intact at the ankles bilaterally. Pattern consistent with a length-dependent sensory polyneuropathy affecting large fiber modalities."

Deep Tendon Reflexes

Document the deep tendon reflexes (DTRs) using the standard 0-4+ scale. Include a schematic if your EHR supports it, or list each reflex individually.

"Reflexes: Biceps 2+ bilaterally. Brachioradialis 2+ bilaterally. Triceps 2+ bilaterally. Patellar 3+ on the right, 2+ on the left. Achilles 0 bilaterally (absent). Plantar responses (Babinski sign): flexor bilaterally. Absent Achilles reflexes in the setting of the sensory findings above are consistent with peripheral nervous system involvement."

Document the plantar response for every complete neurological examination. Extensor plantar responses (Babinski sign) are a significant finding that indicates upper motor neuron pathology and should never be omitted from a note that covers lower extremity examination.

Coordination

The coordination examination tests cerebellar function. Standard tests include finger-nose-finger, heel-to-shin, rapid alternating movements (dysdiadochokinesis), and the Romberg test.

"Coordination: Finger-nose-finger: intact bilaterally, no dysmetria, no intention tremor. Rapid alternating movements: intact bilaterally, no dysdiadochokinesis. Heel-to-shin: intact bilaterally. Romberg test: stable with eyes open, minimal sway with eyes closed, no fall. No truncal ataxia noted on seated exam."

When abnormalities are present, document whether they are lateralized and whether they are worse with eyes closed (suggesting proprioceptive deficit rather than pure cerebellar dysfunction).

Gait

Gait assessment belongs in every complete neurological note. It is one of the highest-yield parts of the exam and one of the most commonly omitted from documentation.

"Gait: Casual gait observed over 10 meters in the hallway. Stance width slightly widened. Arm swing symmetric bilaterally. Stride length mildly reduced. Heel strike intact. No steppage. No circumduction. Tandem gait: slightly unsteady, required wall support on the second attempt but completed without fall. Arising from chair without use of arms. Observation consistent with mild gait ataxia. Timed Up and Go (TUG): 18 seconds (age-adjusted reference range less than 12 seconds)."

If the patient was not ambulatory or the exam was modified due to acute illness, document why: "Gait assessment deferred due to acute right leg weakness and fall risk; patient examined supine and seated."

Neurology-Specific SOAP Note Elements

The SOAP format (Subjective, Objective, Assessment, Plan) applies to neurology, but each section has neurology-specific content requirements.

Subjective

Beyond the chief complaint, the neurological HPI should capture:

• Symptom onset and tempo: Sudden (vascular), subacute over days to weeks (inflammatory, infectious, neoplastic), gradual and progressive over months to years (neurodegenerative)
• Symptom character: Paresthesias vs. weakness vs. pain vs. cognitive change vs. visual disturbance
• Triggering and relieving factors: Particular importance in headache and seizure history
• Associated symptoms: Nausea, photophobia, and phonophobia for headache; aura for seizures; prodrome and postictal period for seizure
• Functional impact: What can the patient no longer do? This matters for both clinical assessment and disability documentation
• Relevant neurological history: Prior strokes, TIAs, seizures, MS, dementia diagnoses
• Medication list with neurological relevance: Antiepileptics, anticoagulants for stroke prevention, dopaminergic agents, medications with known neurotoxicity

Assessment and Plan

In neurology, the Assessment section should do three things: localize, identify the probable etiology, and link both to the diagnostic and treatment plan.

Localization first: Before naming a diagnosis, document your anatomical localization. This is the neurologist's fundamental skill and it should be visible in the note.

"Localization: The combination of right-sided upper and lower extremity weakness with hyperreflexia (right patellar 3+ vs. left 2+) and an extensor plantar response on the right localizes to a lesion in the left corticospinal tract, anywhere from the cortex to the cervical cord. No crossed findings to suggest brainstem localization. Right face involvement would implicate a supratentorial cortical or subcortical lesion above the pons."

Then the etiological reasoning: "Given the acute onset over hours, a vascular etiology is most likely. MRI brain with DWI ordered to evaluate for acute ischemic stroke."

Documenting Cognitive Screening

Cognitive screening is performed routinely in memory clinic visits, neurodegenerative disease follow-up, and whenever cognitive concerns arise. The two most commonly used tools are the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA). Document results with enough detail to be clinically meaningful.

MMSE Documentation

"Mini-Mental State Examination (MMSE) administered today by the neurologist. Total score: 22/30. Subscores: Orientation to time 4/5 (missed month); Orientation to place 5/5; Registration 3/3; Attention and calculation (serial 7s) 3/5; Recall 1/3 (recalled 'apple' but not 'table' or 'penny' with cuing); Language 7/8 (no difficulty naming, repetition intact, followed 3-step command, wrote a full sentence spontaneously, mild difficulty with pentagon copy); Total 22/30. Compared to last assessment [date]: 26/30. Decline of 4 points over [X] months is clinically significant and warrants expanded workup."

MoCA Documentation

"Montreal Cognitive Assessment (MoCA) administered today. Total score: 19/30 (adjusted for 12 years of education: 20/30). Domain scores: Visuospatial/Executive (Trail B, cube copy, clock drawing) 2/5 — difficulty with Trail B and clock command; Naming 3/3; Memory: 0/5 on delayed recall (word list: face, velvet, church, daisy, red — none recalled without category or multiple-choice cuing); Attention 4/6 (target detection 6/6, serial 7s 2/3, digit forward/backward intact); Language 2/3 (phonemic fluency impaired at 8 words, repetition intact, naming intact); Abstraction 1/2; Orientation 6/6. Pattern: worst performance in memory and executive function domains, with relatively preserved orientation and language, consistent with an amnestic-predominant profile."

Always note who administered the test and under what conditions. If vision or hearing impairment limited testing, document that explicitly, as it affects score interpretation.

Seizure Episode Documentation

Seizure documentation requires capturing both the clinical phenomenology and the surrounding clinical context. A well-documented seizure history guides localization, classification under the ILAE framework, and treatment decisions.

Initial Seizure Presentation

For a patient presenting with a first seizure, document the following:

Semiology from the patient and witnesses:

"Ms. Delgado, a 34-year-old right-handed woman, was at work when colleagues observed the following: sudden cessation of activity, fixed rightward gaze lasting approximately 5 seconds, followed by rhythmic jerking of the right arm and then generalization to bilateral clonic activity involving all four limbs. Duration of convulsive activity estimated at 90 seconds by a bystander. Patient unresponsive during event. Post-event: patient required approximately 20 minutes to return to baseline; she reports fatigue and mild headache. She does not recall the event. No history of prior seizures. No prior neurological diagnoses. No family history of epilepsy."

Classify according to the ILAE framework: Document whether the seizure was focal (aware or impaired-awareness) or generalized, and whether it evolved to bilateral tonic-clonic activity.

Provoking factors: Sleep deprivation, alcohol withdrawal, metabolic derangements, fever, medications. These matter because a provoked seizure may have different management implications than an unprovoked one.

EEG and imaging documentation: When results are available, integrate them directly into your note:

"MRI brain with and without contrast: No acute abnormality. No cortical lesion, mass lesion, or mesial temporal sclerosis identified. EEG (awake and drowsy): mild intermittent focal slowing over the left temporal region, no epileptiform discharges captured during recording."

Follow-Up Seizure Documentation

For established epilepsy patients at a follow-up visit, document:

• Seizure frequency since last visit (number of events, with dates if available)
• Seizure type (any change in semiology)
• Antiseizure medication (ASM) current regimen, dose, and adherence
• Drug levels if applicable
• Side effects from ASMs
• Driving status and any counseling provided

Example:

"Mr. Osei, 28-year-old male with focal epilepsy secondary to left temporal cavernous malformation (diagnosed 2022), presents for 6-month follow-up. Since last visit: 3 focal aware seizures with right arm paresthesias lasting 10-15 seconds each (consistent with prior semiology), one of which preceded a focal impaired-awareness event. No secondary generalization. Last major event [date]. Breakthrough seizures follow a period of sleep deprivation related to night-shift work (3 events clustered over one week). Currently on lamotrigine 200 mg BID. Adherence: patient reports missing 2-3 doses over the past 6 months, associated with the breakthrough cluster. Lamotrigine level: 6.2 mcg/mL (therapeutic range 3-15 mcg/mL). No concerning side effects. Driving: patient is currently not driving per state law requiring 6-month seizure-free period; counseled to continue this restriction."

Headache and Migraine Visit Notes

Headache documentation, particularly for migraine, needs to capture phenotype, frequency, functional impact, and the response to acute and preventive treatments. Headache frequency and disability burden often determine the threshold for initiating preventive therapy.

First Headache Visit

"Ms. Park, a 29-year-old female, presents with a 4-year history of episodic headaches occurring 6-8 times per month. Headache phenotype: unilateral (left-sided in approximately 70% of episodes), pulsating quality, moderate-to-severe intensity (7-8/10 at peak), aggravated by physical activity. Associated symptoms consistently include nausea and photophobia; phonophobia present in approximately half of episodes; no vomiting. Duration 6-18 hours untreated. Aura: patient describes a 15-20 minute episode of visual disturbance (zigzag lines in the right visual field, slowly expanding) preceding the headache in about one-third of episodes. No motor, sensory, or speech aura. MIDAS score: 21 (Grade III, moderate disability). Current acute treatment: ibuprofen 600 mg — partially effective. Has never tried triptans. No prior preventive therapy. Contraindications to triptans reviewed: no cardiovascular disease, no hemiplegic migraine, no basilar features. Family history: mother with migraine."

Document the ICHD-3 diagnosis clearly in your Assessment: "Migraine with aura (ICHD-3 1.2), episodic, currently at 6-8 attacks/month."

Follow-Up Headache Visit

Use a headache diary summary if the patient kept one, and document changes in frequency compared to baseline:

"Follow-up at 3 months. Patient has been keeping a headache diary since last visit. Current frequency: 3-4 migraines per month, down from 6-8 at baseline. Preventive medication: topiramate 50 mg nightly, initiated 10 weeks ago (current dose after titration). Side effects: mild word-finding difficulty noted in the first 4 weeks, improved but not fully resolved at current dose. Cognitive symptoms are tolerable to patient at this time. MIDAS score today: 9 (Grade II, mild disability), down from 21 at last visit. Acute treatment: sumatriptan 100 mg — patient reports good response in approximately 70% of treated attacks when taken early. Average triptan use: 3-4 per month."

Stroke Follow-Up Documentation

Stroke follow-up notes need to track neurological recovery, secondary prevention measures, and modifiable risk factor control. The trajectory of deficits from admission to follow-up is clinically and legally important.

Establishing the Baseline and Tracking Recovery

Always reference the admission neurological examination when describing the current visit:

"Mr. Tanaka, a 67-year-old male, presents for 3-month stroke follow-up. History: ischemic stroke, left MCA territory, presenting with acute right-sided weakness and expressive aphasia (NIH Stroke Scale 14 on admission). Intravenous thrombolysis administered within 3.2 hours of symptom onset. Admission MRI: acute DWI-positive cortical and subcortical infarct in the left frontoparietal region.

Current neurological examination: Cranial nerves: CN II-XII intact. Motor: right arm strength 4/5 at shoulder and elbow, 3+/5 at wrist and hand; right leg strength 4+/5 throughout; left side 5/5. Reflexes: right-sided hyperreflexia, right patellar 3+ vs. left 2+; right Babinski extensor. Language: spontaneous speech fluent with occasional word-finding pauses; naming 8/10 on bedside testing; repetition intact; comprehension intact to multi-step commands. No dysarthria. Gait: mild right circumduction at hip, no assistive device required at this time.

Compared to discharge examination [date]: significant improvement in right hand strength (2/5 at discharge vs. 3+/5 today) and language production (non-fluent with effortful output at discharge vs. fluent with occasional pauses today)."

Secondary Prevention Documentation

"Secondary prevention: Etiology determined as cardioembolic (paroxysmal atrial fibrillation detected on 14-day cardiac monitor, 3 separate episodes, longest 4.2 hours). Currently on apixaban 5 mg BID initiated [date]. INR not applicable (NOAC). Blood pressure: 128/76 today; home log average over past 2 weeks: 132/80. LDL: 68 mg/dL on atorvastatin 40 mg. HbA1c: 6.1%. Lifestyle: patient reports adherence to low-sodium diet and is walking 20 minutes daily. Smoking cessation: patient stopped smoking on the day of his stroke and has not resumed."

Capturing Complex Findings in Billable Notes

Neurology visits frequently justify higher-level E&M billing (99214-99215 for established patients, 99204-99205 for new patients) because of the complexity of medical decision-making and the extensive nature of the neurological examination. Your documentation needs to support that complexity.

Common documentation gaps that reduce the supported billing level:

• A thorough exam documented, but a one-line Assessment that gives no clinical reasoning
• Medication adjustments documented without rationale or risk discussion
• Complex imaging results reviewed but not integrated into the Assessment
• Multiple active neurological problems managed but only one addressed in the Plan

For a 99215 or 99205, your note should reflect: multiple diagnoses or a new problem with significant workup, review and ordering of extensive diagnostic tests, and/or complex medical decision-making with explicit reasoning. The level is supported by the complexity of the work, which must be visible in what you write.

Tools like NotuDocs let neurologists build structured templates that prompt for each examination domain, ensuring no section is omitted at the point of documentation rather than discovered missing at billing or audit review. The template captures the framework; your clinical findings and reasoning fill it in.

Neurology Documentation Checklist

Complete Neurological Examination

• Mental status: alertness, orientation, language, memory, executive function (at minimum)
• Cranial nerves I-XII individually documented or grouped with notation of any abnormality
• Motor: bulk, tone, and strength by muscle group with MRC grading
• Sensory: modalities tested, distribution of any abnormality documented
• Reflexes: DTRs scored 0-4+ for each reflex; plantar responses documented
• Coordination: finger-nose-finger, heel-to-shin, rapid alternating movements, Romberg
• Gait: observed and described; TUG or other quantitative measure when applicable

Neurology SOAP Note

• HPI includes onset tempo, symptom character, functional impact, and relevant prior neurological history
• Assessment begins with anatomical localization before etiological diagnosis
• Differential diagnosis includes reasoning for and against leading possibilities
• Plan directly linked to clinical reasoning

Cognitive Screening

• Test administered documented by name and version (MMSE or MoCA)
• Total score and domain scores or subscores documented
• Comparisons to prior scores with interval specified
• Factors affecting test validity noted (vision, hearing, education, language)

Seizure Notes

• Semiology documented from patient and witness accounts
• ILAE seizure classification applied
• Provoking factors assessed and documented
• For follow-up: frequency, adherence, ASM levels, driving status, side effects

Headache and Migraine Notes

• Phenotype documented: location, quality, severity, duration, associated symptoms
• Aura description if present
• Frequency per month; MIDAS or HIT-6 score
• Acute medication response documented
• ICHD-3 diagnosis stated in Assessment

Stroke Follow-Up Notes

• Reference to admission neurological examination and deficits
• Current examination with comparison to prior
• Stroke etiology documented
• Secondary prevention measures listed with specific agents, doses, and targets
• Rehabilitation services engaged and progress noted

Billing Support

• Complexity of medical decision-making visible in the Assessment and Plan
• Multiple active problems addressed individually in the Plan
• Risk of new diagnoses, extensive workup, or complex management explicitly reflected

---

Related guides:

• Clinical Documentation for Medical Residents
• How to Document Chronic Pain Management and Opioid Prescribing
• How to Document Dermatology Visits and Skin Examination Findings